Results 51 to 60 of about 1,170 (185)
Echocardiographic evaluation of cardiovascular effects of amrinone
Amrinone, a new inotropic drug, was infused at a dosage of 2.5 mg/kg body weight in 14 patients affected by dilatative cardiomyopathy in New York Heart Association (NYHA) functional class III and IV.
MATTIOLI, Giorgio +5 more
core +1 more source
Amrinone potentiates catecholamine-induced lipolysis in fat cells
Am&tone, a bipyridine derivative, exerts a positive inotropic action in vitro 11-31 and in viuo 141. In addition, the drug produces a marked relaxation of vascular [5,6] and intestinal [5,7-91 smooth muscle.
Gaion, R M +4 more
core +1 more source
Clinical applications of amrinone
A bipyridine derivative, amrinone is a noncatecholamine, nonglycoside alternative in the treatment of perioperative myocardial dysfunction. A type-3 phosphodiesterase enzyme inhibitor, amrinone combines positive inotropic support with systemic and pulmonary vasodilation.
openaire +2 more sources
Effect of amrinone on mucosal permeability in experimental intestinal ischaemia/reperfusion injury
Background: The preventive effect of amrinone on ischaemia/reperfusion (I/R) injury has been shown in the medical literature. The purpose of the present study was to investigate the preventive effect of amrinone on I/R injury of the small bowel of the ...
Kale, N +11 more
core +1 more source
In rabbit papillary muscles, the pronounced inotropic effect of amrinone (0.4–0.8 mg/mL) observed at low stimulation frequencies (0.1–0.5 Hz) diminished as the frequency was increased to 1.0–2.0 Hz. Reversal of the negative inotropic effect of halothane
Ben F. Rusy, Hirochika Komai
core +1 more source
Effect of amrinone on right ventricular function: predominance of afterload reduction.
Although the bipyridine agent amrinone is reported to have a positive inotropic effect on the left ventricle, the effect of this drug on right ventricular contractility in the clinical setting is unknown.
M J Aronovitz +5 more
core +1 more source
Vesnarinone and amrinone reduce the systemic inflammatory response syndrome
Objective: The systemic inflammatory response is an important cause of organ dysfunction. The present study tested the hypothesis that 2 clinically used agents, amrinone and vesnarinone, would decrease inflammation and cardiac dysfunction in a relevant ...
del Nido, Pedro J. +8 more
core +1 more source
Combination of norepinephrine and amrinone in the treatment of endotoxin shock
The combination of phosphodiesterase inhibitors and adrenergic agents represents an interesting option to increase cardiac output in acute circulatory failure.
Coussaert, Edouard +6 more
core +1 more source
A number of uncontrolled studies have indicated that oral administration of amrinone, a phosphodiesterase inhibitor with potent positive inotropic effects in experimental preparations, may be beneficial in patients with chronic congestive heart failure ...
M Packer +6 more
core +1 more source

